Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Clinical Trial ID NCT03590808

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03590808

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010 10.59
2 Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol 2015 2.09
3 Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles. Cancer 2016 1.39
4 Utility of influenza vaccination for oncology patients. J Clin Oncol 2010 1.15
5 Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017 0.99
6 NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw 2017 0.75
7 Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017 0.75
Next 100